Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Da Huo Luo Wan is a traditional Chinese medicine (TCM) herbal formulation manufactured by Yaodu Zhangshu Pharmaceutical (a subsidiary of Renhe Group). It is a complex multi-ingredient medication containing 48 herbal and animal-derived components, including pit viper (Qishe), Wushao snake, Weiling immortal, artificial musk, and red ginseng. The formulation is designed to dispel wind, eliminate dampness and phlegm, relax tendons, and activate collaterals. It is primarily indicated for the treatment of paralysis resulting from stroke with phlegm obstruction, as well as foot atrophy, muscle spasms, lower back and leg pain, traumatic injuries, and chest pain. The drug is an approved oral medication in China, available in pill form (both small and large honey pills).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Da Huo Luo Wan.